Protecting against Respiratory tract Infections through human Milk Analysis.
- Conditions
- (respiratory) infections and allergic diseases.
- Registration Number
- NL-OMON23847
- Lead Sponsor
- utricia reserach bv.
- Brief Summary
n.a.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1000
All mother-child dyads that live in a proximity to Utrecht (because of logistical issues) and/or gave birth at the WKZ.
- Parents should have the intention to continue breastfeeding until at least 3 months postpartum
- Concerning the child:
(inborn) severe cardiac or pulmonary disorders or other severe organ diseases
- Extreme prematurity (defined as GA<32 weeks).
- Concerning parents:
- Acquired or innate immune deficiencies (excluding asthma, eczema and allergies).
- The (lactating) mother receives medication or has a physical condition which forms a contraindication for breastfeeding.
- Insufficient control of the Dutch language (i.e. at least B1 level).
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parent-reported medically attended respiratory tract infection during the first year of life
- Secondary Outcome Measures
Name Time Method Other infections during the first year of life (non-MARI respiratory tract infections but also gastro-intestinal infections).<br>Allergic diseases developed during first year of life.